Company Filing History:
1 out of 15,515 
1 out of 24 Years Active: 2020
Title: Miguel Garcia-Guzmàn: Innovator in Pain and Inflammation Treatment
Introduction
Miguel Garcia-Guzmàn is a notable inventor based in San Diego, California. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for pain and inflammatory conditions.
Latest Patents
Garcia-Guzmàn holds a patent for "Piperazinyl methanone NAAA inhibitors." This patent discloses compositions and methods for modulating the activity of N-acylethanolamine acid amidase, which can be utilized for treating various pathological states, including pain, inflammatory conditions, and neurodegenerative disorders. He has 1 patent to his name.
Career Highlights
Throughout his career, Garcia-Guzmàn has worked with prestigious institutions, including the University of California and the Fondazione Istituto Italiano Di Technologia. His work has focused on innovative approaches to address complex medical issues.
Collaborations
Garcia-Guzmàn has collaborated with esteemed colleagues such as Daniele Piomelli and Rita Scarpelli. These partnerships have furthered research and development in the field of pain management and inflammation.
Conclusion
Miguel Garcia-Guzmàn is a dedicated inventor whose work has the potential to significantly impact the treatment of pain and inflammatory disorders. His innovative approaches and collaborations highlight his commitment to advancing medical science.